tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AMPH Stock Latest News

Amphastar Signs $2.8M Research Agreement with Hanxin
Company AnnouncementsAmphastar Signs $2.8M Research Agreement with Hanxin
12d ago
8K
AMPH
Amphastar price target raised to $32 from $28 at BofA
PremiumThe Fly
Amphastar price target raised to $32 from $28 at BofA
1M ago
AMPH
Amphastar Pharmaceuticals’ Mixed Earnings Call Highlights
PremiumCompany Announcements
Amphastar Pharmaceuticals’ Mixed Earnings Call Highlights
2M ago
AMPH
Amphastar Pharmaceuticals: Strategic Positioning and Robust Pipeline Justify Buy Rating
PremiumRatings
Amphastar Pharmaceuticals: Strategic Positioning and Robust Pipeline Justify Buy Rating
2M ago
AMPH
Amphastar announced FDA approval of iron sucrose injection
PremiumThe Fly
Amphastar announced FDA approval of iron sucrose injection
2M ago
AMPH
Needham upgrades Amphastar on valuation post AMP-002 approval
PremiumThe FlyNeedham upgrades Amphastar on valuation post AMP-002 approval
2M ago
AMPH
VTRS
Amphastar upgraded to Buy from Hold at Needham
Premium
The Fly
Amphastar upgraded to Buy from Hold at Needham
2M ago
AMPH
Amphastar Pharmaceuticals Enters Strategic Licensing Agreement
Premium
Company Announcements
Amphastar Pharmaceuticals Enters Strategic Licensing Agreement
2M ago
8K
AMPH
Cautious Hold Rating on Amphastar Pharmaceuticals Amid Uncertain Product Approvals and Flat Revenue Growth
PremiumRatings
Cautious Hold Rating on Amphastar Pharmaceuticals Amid Uncertain Product Approvals and Flat Revenue Growth
2M ago
AMPH
Amphastar price target lowered to $25 from $30 at Piper Sandler
PremiumThe Fly
Amphastar price target lowered to $25 from $30 at Piper Sandler
2M ago
AMPH
Amphastar Pharmaceuticals Reports Q2 2025 Earnings Highlights
PremiumCompany Announcements
Amphastar Pharmaceuticals Reports Q2 2025 Earnings Highlights
2M ago
AMPH
Amphastar sees Q3 adjusted EPS 77c-79c, consensus 69c
PremiumThe Fly
Amphastar sees Q3 adjusted EPS 77c-79c, consensus 69c
2M ago
AMPH
Amphastar announces multi-year expansion of California manufacturing operations
PremiumThe FlyAmphastar announces multi-year expansion of California manufacturing operations
3M ago
AMPH
Amphastar Pharmaceuticals Stockholders Approve Key Amendments
Premium
Company Announcements
Amphastar Pharmaceuticals Stockholders Approve Key Amendments
4M ago
8K
AMPH
FTC renews Orange Book listing disputes
Premium
The Fly
FTC renews Orange Book listing disputes
4M ago
NVS
AMPH
Target downgraded, Wayfair upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Target downgraded, Wayfair upgraded: Wall Street’s top analyst calls
5M ago
W
ON
Amphastar downgraded to Neutral from Overweight at JPMorgan
PremiumThe Fly
Amphastar downgraded to Neutral from Overweight at JPMorgan
5M ago
AMPH
Amphastar Pharmaceuticals’ Mixed Earnings Call Insights
PremiumCompany Announcements
Amphastar Pharmaceuticals’ Mixed Earnings Call Insights
5M ago
AMPH
Amphastar price target lowered to $35 from $40 at Wells Fargo
PremiumThe Fly
Amphastar price target lowered to $35 from $40 at Wells Fargo
5M ago
AMPH
Cautious Hold Rating for Amphastar Pharmaceuticals Amid Competitive Pressures and Revenue Challenges
PremiumRatingsCautious Hold Rating for Amphastar Pharmaceuticals Amid Competitive Pressures and Revenue Challenges
5M ago
AMPH
Amphastar Pharmaceuticals: Neutral Stance Amid Mixed Financial Outlook and Pipeline Uncertainty
Premium
Ratings
Amphastar Pharmaceuticals: Neutral Stance Amid Mixed Financial Outlook and Pipeline Uncertainty
5M ago
AMPH
Amphastar Pharmaceuticals Reports Q1 2025 Earnings
Premium
Company Announcements
Amphastar Pharmaceuticals Reports Q1 2025 Earnings
5M ago
AMPH

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >